EUVIMED · CrossrefZeitschrift
ESC Heart Failure
ISSN 2055-5822 · Oxford University Press (OUP)
Neueste Artikel
Diuretic Response in Acute Heart Failure: Prediction vs Direct Measurement
Adoption of ESC Guideline-Directed Heart Failure Pharmacotherapy and Outcomes: A Nationwide Claims-Based Cohort Study
Angiotensin receptor neprilysin inhibitors and renal outcomes in patients with heart failure: a systematic review and meta-analysis
Mitral regurgitation and all-cause mortality in acute heart failure: a meta-analysis
Differential rates of guideline-directed medical therapy modification in C-MIC and control patients: results from the C-MIC II trial
Exercise for older people with heart failure and frailty: should we even try?
Utilizing a Substitute Pulmonary Artery Pressure Sensor System due to Unreliable Pulmonary Artery Pressure Readings
Sex-Specific Mechanisms and Therapeutics in Heart Failure: Translating Biology into Personalized Care
Sex-Specific Prognostic Significance of Interventricular Septal Thickness in Heart Failure
New Evidence in Heart Failure: 2026 Update
Cost-effectiveness of TTVR with EVOQUE system in patients with severe tricuspid regurgitation based on TRISCEND II trial
Contemporary real-world treatment of cardiac transthyretin amyloidosis with tafamidis: a long-term multicentre study
Dapagliflozin effects on right ventricular function, pulmonary pressure and coupling: a propensity score analysis from the RIVED-HF
Five-year outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation: results from the Tendyne Expanded Clinical Study
Severe tricuspid regurgitation: aetiology, patient characteristics, and treatment: a multicentre, prospective registry
Frailty and Heart Failure: An Integrated Review of a Bidirectional Relationship
Novel biomarkers distinguish heart failure with preserved vs reduced ejection fraction
Effects of empagliflozin on right ventricular free-wall strain in patients with heart failure and reduced ejection fraction: results from the Empire HF Trial
Effect of sodium-glucose cotransporter-2 inhibitors on haemoglobin and haematocrit levels in heart failure: a systematic review and meta-analysis
Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: design and rationale of the Reduce-MFA DZHK25 trial
Glucagon-like peptide-1 receptor agonists in patients with heart failure with reduced ejection fraction
Evaluation and management of recent onset cardiomyopathy in the current era of heart failure therapeutics: a clinical consensus statement of the Heart Failure Association of the ESC
Impact of routine urine sodium evaluation on diuretic practices in patients with acute heart failure
The quantitative haemodynamic effect of levosimendan, dobutamine, and milrinone in heart failure patients: a meta-analysis
Quantifying skeletal muscle energy metabolism during exercise in heart failure with preserved ejection fraction using in vivo 31P magnetic resonance spectroscopy
Cardiovascular risk associated with polypharmacy in heart failure: a systematic review and meta-analysis
Medical treatments at 6 months in hospitalized and ambulatory HFrEF patients in the BRING-UP 3 Heart Failure study
Invasive haemodynamic validation of an artificial intelligence echocardiographic tool for detecting heart failure with preserved ejection fraction
Cardiogenic shock in the course of myocardial infarction: the results of the Shock-POL registry
Genetic evidence for GLP1R agonists in non-ischaemic heart failure
EUVIMED